GlaxoSmithKline Pakistan Limited

KASE:GLAXO Stock Report

Market Cap: PK₨122.0b

GlaxoSmithKline Pakistan Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Erum Rahim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.8yrs
CEO ownershipn/a
Management average tenure2.8yrs
Board average tenure4.7yrs

Recent management updates

Recent updates

CEO

Erum Rahim

4.8yrs

Tenure

Ms. Erum Shakir Rahim serves as the Chief Executive Officer at GlaxoSmithKline Pakistan Limited since 2021 and served as its Vice President and General Manager since 2021 until May 2023. She served as Non-...

Leadership Team

NamePositionTenureCompensationOwnership
Erum Rahim
CEO & Executive Director4.8yrsno datano data
Hasham Baber
CFO & Executive Director3.5yrsno datano data
Syed Raza Alam
Tech Head6yrsno datano data
Faisal Ahmad
Head of Country Ethics & Compliance1.7yrsno datano data
Hina Mir
Legal Director & Company Secretaryless than a yearno datano data
Sumera Naveed
Director Communication & Government Affairsno datano datano data
Sabiqa Kiani
Country Head of HRless than a yearno datano data
Gohar Khan
Head of Regulatory Affairs4.9yrsno datano data
Yasir Rehman
Head of Transformation2.2yrsno datano data
Ovais Farooq
Chief Internal Auditorno datano datano data

2.8yrs

Average Tenure

Experienced Management: GLAXO's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Erum Rahim
CEO & Executive Director4.8yrsno datano data
Hasham Baber
CFO & Executive Director3.5yrsno datano data
Muneer Kamal
Independent Director4.7yrsno datano data
Maheen Rahman
Independent Director6yrsno datano data
Mehmood Mandviwalla
Non-Executive Director13.6yrsno datano data
Lai Goh
Non Executive Chairman2.3yrsno datano data
Simon Foster
Non-Executive Director2.3yrsno datano data

4.7yrs

Average Tenure

Experienced Board: GLAXO's board of directors are considered experienced (4.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 01:48
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GlaxoSmithKline Pakistan Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution